BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND LASP1, ENSG00000002834, 3927, Q14847, MLN50, Lasp-1
11 results:

  • 1. Acute monocytic leukemia with KMT2A::lasp1 developed 9 months after diagnosis of acute megakaryoblastic leukemia in a 2-year-old boy.
    Fujita T; Fukushima H; Nanmoku T; Arakawa Y; Deguchi T; Suzuki R; Yamaki Y; Hosaka S; Takada H
    Int J Hematol; 2023 Oct; 118(4):514-518. PubMed ID: 37314622
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Phosphorylation-Dependent Differences in CXCR4-lasp1-AKT1 Interaction between Breast Cancer and Chronic Myeloid leukemia.
    Butt E; Stempfle K; Lister L; Wolf F; Kraft M; Herrmann AB; Viciano CP; Weber C; Hochhaus A; Ernst T; Hoffmann C; Zernecke A; Frietsch JJ
    Cells; 2020 Feb; 9(2):. PubMed ID: 32075106
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association of long non-coding RNA and leukemia: A systematic review.
    Dieter C; Lourenco ED; Lemos NE
    Gene; 2020 Apr; 735():144405. PubMed ID: 32014562
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Knockout of lasp1 in CXCR4 expressing CML cells promotes cell persistence, proliferation and TKI resistance.
    Herrmann AB; Müller ML; Orth MF; Müller JP; Zernecke A; Hochhaus A; Ernst T; Butt E; Frietsch JJ
    J Cell Mol Med; 2020 Mar; 24(5):2942-2955. PubMed ID: 31957290
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Outcomes and Predictors of Mortality for Patients with Acute leukemia Admitted to the Intensive Care Unit.
    Kraguljac AP; Croucher D; Christian M; Ibrahimova N; Kumar V; Jacob G; Kiss A; Minden MD; Mehta S
    Can Respir J; 2016; 2016():3027656. PubMed ID: 27445524
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Functional characterisation of different MLL fusion proteins by using inducible Sleeping Beauty vectors.
    Wächter K; Kowarz E; Marschalek R
    Cancer Lett; 2014 Oct; 352(2):196-202. PubMed ID: 25016062
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. lasp1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia.
    Frietsch JJ; Kastner C; Grunewald TG; Schweigel H; Nollau P; Ziermann J; Clement JH; La Rosée P; Hochhaus A; Butt E
    Oncotarget; 2014 Jul; 5(14):5257-71. PubMed ID: 24913448
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Functional analysis of the two reciprocal fusion genes MLL-NEBL and NEBL-MLL reveal their oncogenic potential.
    Emerenciano M; Kowarz E; Karl K; de Almeida Lopes B; Scholz B; Bracharz S; Meyer C; Pombo-de-Oliveira MS; Marschalek R
    Cancer Lett; 2013 May; 332(1):30-4. PubMed ID: 23340173
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes.
    Schulte I; Batty EM; Pole JC; Blood KA; Mo S; Cooke SL; Ng C; Howe KL; Chin SF; Brenton JD; Caldas C; Howarth KD; Edwards PA
    BMC Genomics; 2012 Dec; 13():719. PubMed ID: 23260012
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants.
    Strehl S; König M; Meyer C; Schneider B; Harbott J; Jäger U; von Bergh AR; Loncarevic IF; Jarosova M; Schmidt HH; Moore SD; Marschalek R; Haas OA
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1041-9. PubMed ID: 16897742
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The human lasp1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21).
    Strehl S; Borkhardt A; Slany R; Fuchs UE; König M; Haas OA
    Oncogene; 2003 Jan; 22(1):157-60. PubMed ID: 12527918
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.